Detalles de la búsqueda
1.
Sensitive and robust liquid biopsy-based detection of PIK3CA mutations in hormone-receptor-positive metastatic breast cancer patients.
Br J Cancer
; 126(3): 456-463, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34754095
2.
Comparing linear discriminant analysis and supervised learning algorithms for binary classification-A method comparison study.
Biom J
; 2022 Dec 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36529690
3.
Sensitive and broadly applicable residual disease detection in acute myeloid leukemia using flow cytometry-based leukemic cell enrichment followed by mutational profiling.
Am J Hematol
; 95(10): 1148-1157, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32602117
4.
G protein-coupled receptor GPR55 promotes colorectal cancer and has opposing effects to cannabinoid receptor 1.
Int J Cancer
; 142(1): 121-132, 2018 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28875496
5.
Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamide.
Int J Cancer
; 143(5): 1236-1248, 2018 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29574703
6.
Residual disease detection using targeted parallel sequencing predicts relapse in cytogenetically normal acute myeloid leukemia.
Am J Hematol
; 93(1): 23-30, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28960408
7.
TP53 mutated AML subclones exhibit engraftment in a humanized bone marrow ossicle mouse model.
Ann Hematol
; 99(3): 653-655, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32002654
8.
Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1.
Mod Pathol
; 27(6): 906-15, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24309322
9.
Detection of AML-specific TP53 mutations in bone marrow-derived mesenchymal stromal cells cultured under hypoxia conditions.
Ann Hematol
; 98(8): 2019-2020, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30941510
10.
Persistence of ctDNA in Patients with Breast Cancer During Neoadjuvant Treatment Is a Significant Predictor of Poor Tumor Response.
Clin Cancer Res
; 28(4): 697-707, 2022 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34862246
11.
Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T-cell lymphoma.
EMBO Mol Med
; 14(12): e15200, 2022 12 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36341492
12.
Longitudinal tumor fraction trajectories predict risk of progression in metastatic HR+ breast cancer patients undergoing CDK4/6 treatment.
Mol Oncol
; 15(9): 2390-2400, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33264486
13.
Dynamic Changes of Circulating Tumor DNA Predict Clinical Outcome in Patients With Advanced Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
JCO Precis Oncol
; 5: 1540-1553, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34994642
14.
On-treatment measurements of circulating tumor DNA during FOLFOX therapy in patients with colorectal cancer.
NPJ Precis Oncol
; 4(1): 30, 2020 Nov 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33299124
15.
Comparison of three commercial decision support platforms for matching of next-generation sequencing results with therapies in patients with cancer.
ESMO Open
; 5(5): e000872, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32967919
16.
Exome sequence analysis in consanguineous Pakistani families inheriting Bardet-Biedle syndrome determined founder effect of mutation c.299delC (p.Ser100Leufs*24) in BBS9 gene.
Mol Genet Genomic Med
; 7(8): e834, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31294530
17.
Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer.
Nat Commun
; 7: 12008, 2016 06 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-27328849
18.
Inferring expressed genes by whole-genome sequencing of plasma DNA.
Nat Genet
; 48(10): 1273-8, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27571261
Resultados
1 -
18
de 18
1
Próxima >
>>